Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Pfizer
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:developsTherapiesFor |
gptkb:Duchenne_muscular_dystrophy
rare neuromuscular diseases |
| gptkbp:focusesOn |
rare diseases
gene therapy |
| gptkbp:foundedIn |
2014
|
| gptkbp:hasFacility |
GMP manufacturing facility
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bamboo Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Chapel_Hill,_North_Carolina
|
| gptkbp:parentCompany |
gptkb:Pfizer
|
| gptkbp:specializesIn |
AAV vector gene therapies
|
| gptkbp:bfsParent |
gptkb:AveXis
|
| gptkbp:bfsLayer |
5
|